In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Puma Biotechnology Inc (NASDAQ: PBYI) closed at $2.42 in the last session, down -19.06% from day before closing price of $2.99. In other words, the price has decreased by -$19.06 from its previous closing price. On the day, 1.54 million shares were traded. PBYI stock price reached its highest trading level at $3.01 during the session, while it also had its lowest trading level at $2.35.
Ratios:
We take a closer look at PBYI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.85. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.21 whereas as Long-Term Debt/Eq ratio is at 0.50.
Goldman Downgraded its Neutral to Sell on October 08, 2019, whereas the target price for the stock was revised from $24 to $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when MILLER MICHAEL PATRICK sold 23,358 shares for $3.49 per share. The transaction valued at 81,466 led to the insider holds 47,000 shares of the business.
MILLER MICHAEL PATRICK bought 23,358 shares of PBYI for $87,826 on Aug 12 ’24. On Jul 17 ’24, another insider, NOUGUES MAXIMO F, who serves as the Chief Financial Officer of the company, sold 4,156 shares for $3.70 each. As a result, the insider received 15,382 and left with 162,522 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBYI now has a Market Capitalization of 118792240 and an Enterprise Value of 108437192. As of this moment, Puma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.10, and their Forward P/E ratio for the next fiscal year is 7.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 1.67. Its current Enterprise Value per Revenue stands at 0.445 whereas that against EBITDA is 2.432.
Stock Price History:
Over the past 52 weeks, PBYI has reached a high of $7.73, while it has fallen to a 52-week low of $2.22. The 50-Day Moving Average of the stock is -11.43%, while the 200-Day Moving Average is calculated to be -38.64%.
Shares Statistics:
According to the various share statistics, PBYI traded on average about 352.06K shares per day over the past 3-months and 818870 shares per day over the past 10 days. A total of 47.65M shares are outstanding, with a floating share count of 35.19M. Insiders hold about 28.31% of the company’s shares, while institutions hold 54.30% stake in the company. Shares short for PBYI as of 1730332800 were 3188854 with a Short Ratio of 9.06, compared to 1727654400 on 3411953. Therefore, it implies a Short% of Shares Outstanding of 3188854 and a Short% of Float of 7.66.
